The OD2A Health Equity Needs Assessment is designed to assess the support, technical assistance, and training that state, local, and territorial health agencies need to move health equity forward within their OD2A programs.
The Senate released its version of the FY25 LHHS appropriation bill on August 1, 2024, with significant changes in proposed public health funding than the House's proposed bill.
ASTHO CEO Michael Fraser looks back on nine of the top public health highlights in 2019.
Neonatal Abstinence Syndrome (NAS) has become more prevalent in the United States, with the hospitalization rate increasing from 2.9 to 7.3 hospitalizations per 1,000 newborn births between 2009 and 2017. NAS occurs in newborns who ...
This page features ASTHO’s legal mapping work to plot the legal landscape for public health priorities.
Interest is using psilocybins to treat some disorders has reemerged. Some states are taking steps to put that interest into practice.
Overdose Prevention Policy Considerations: A Policy Playbook for State and Territorial Health Officials and Agencies overdose prevention, drug checking equipment, syringe services, health equity, reducing stigma, discriminatory policies, ...
States have begun to expand their focus when developing new approaches to improve surveillance, promote harm reduction, create linkages to care, and educate providers on opioid overdose reduction.
As 2019 comes to a close, it is important to reflect back on the numerous public health accomplishments and acknowledge the ongoing challenges we can expect to face in 2020.
State and local jurisdictions are developing Ending the HOV Epidemic plans. The EHE initiative has largely focused on four key strategies: Diagnose, Treat, Prevent, and Respond to potential outbreaks. The EHE initiative set a goal to ...
ASTHO interview with Elizabeth Harvey, PhD, MPH, a CDC Senior Maternal and Child Health Epidemiology Program assignee to the Tennessee Department of Health. Harvey shares her thoughts on the progress Tennessee has made on opioid use ...
A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.
ASTHO conducted focus groups to examine overdose-related issues and identify potential engagement opportunities for public health and public safety around overdose prevention. This brief outlines key takeaways and is designed to serve as a ...
This brief outlines key considerations for state health departments to keep in mind as they create financing, data, and policy partnerships with behavioral health stakeholders.
This ASTHOReport highlights the public health importance of three harm reduction policies and practices to reduce overdoses: facilitating community distribution of naloxone, facilitating community distribution of fentanyl test strips, and ...
State and territorial health agencies continue to be challenged by the opioid epidemic, which has been exacerbated by the COVID-19 pandemic. Addressing the opioid crisis requires a robust public health response, which could be helped by ...
With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important topic for policy makers. The number of ...
The opioid crisis continues to claim the lives of thousands across the United States and has cost the economy billions in health care, mortality, and criminal justice costs. In 2018, it’s estimated that 67,367 people died of overdose, with ...
Overdose fatality reviews allow states to examine and understand the circumstances surrounding fatal drug overdoses. Knowing the who, what, when, where, and how of fatal overdoses provides a better sense of the strategies and coordination ...
How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...